Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of New Technology To Improve Delivery of Immunizations, Funding Opportunity Announcement (FOA) IP09-005 Initial Review; Development, Implementation and Evaluation of Strategies To Increase Vaccination of Adolescents Affiliated With a Medical Home, FOA IP09-006 Initial Review; Determine the Impact of Strategies To Vaccinate All Children for Influenza in a Practice Setting, FOA IP09-007, Initial Review

---
identifier: "/us/fr/E9-10190"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of New Technology To Improve Delivery of Immunizations, Funding Opportunity Announcement (FOA) IP09-005 Initial Review; Development, Implementation and Evaluation of Strategies To Increase Vaccination of Adolescents Affiliated With a Medical Home, FOA IP09-006 Initial Review; Determine the Impact of Strategies To Vaccinate All Children for Influenza in a Practice Setting, FOA IP09-007, Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "E9-10190"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of New Technology To Improve Delivery of Immunizations, Funding Opportunity Announcement (FOA) IP09-005 Initial Review; Development, Implementation and Evaluation of Strategies To Increase Vaccination of Adolescents Affiliated With a Medical Home, FOA IP09-006 Initial Review; Determine the Impact of Strategies To Vaccinate All Children for Influenza in a Practice Setting, FOA IP09-007, Initial Review"
positive_law: false
currency: "2009-05-04"
last_updated: "2009-05-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-10190"
document_type: "notice"
publication_date: "2009-05-04"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 20487"
fr_volume: 74
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of New Technology To Improve Delivery of Immunizations, Funding Opportunity Announcement (FOA) IP09-005 Initial Review; Development, Implementation and Evaluation of Strategies To Increase Vaccination of Adolescents Affiliated With a Medical Home, FOA IP09-006 Initial Review; Determine the Impact of Strategies To Vaccinate All Children for Influenza in a Practice Setting, FOA IP09-007, Initial Review

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Dates:*

8 a.m.-5 p.m., May 21, 2009 (Closed).

8 a.m.-5 p.m., May 22, 2009 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the initial review, discussion, and evaluation of “Evaluation of New Technology to Improve Delivery of Immunizations, FOA IP09-005;” “Development, Implementation and Evaluation of Strategies to Increase Vaccination of Adolescents Affiliated with a Medical Home, FOA IP09-006;” “Determine the Impact of Strategies to Vaccinate all Children for Influenza in a Practice Setting, FOA IP09-007.”

*Contact Person for More Information:* Wendy Carr, PhD, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2276.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 24, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.